151 related articles for article (PubMed ID: 36420541)
1. Urea as safe treatment for hyponatremia due to syndrome of inappropriate antidiuretic hormone in infant with solitary central incisor and neurofibromatosis-1.
Cui J; Halpin K; Paprocki E
J Pediatr Endocrinol Metab; 2023 Apr; 36(4):430-434. PubMed ID: 36420541
[TBL] [Abstract][Full Text] [Related]
2. Inappropriate antidiuretic hormone secretion: long-term successful urea treatment.
Chehade H; Rosato L; Girardin E; Cachat F
Acta Paediatr; 2012 Jan; 101(1):e39-42. PubMed ID: 21672011
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea.
Decaux G; Brimioulle S; Genette F; Mockel J
Am J Med; 1980 Jul; 69(1):99-106. PubMed ID: 7386514
[TBL] [Abstract][Full Text] [Related]
4. Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children.
Huang EA; Feldman BJ; Schwartz ID; Geller DH; Rosenthal SM; Gitelman SE
J Pediatr; 2006 Jan; 148(1):128-31. PubMed ID: 16423613
[TBL] [Abstract][Full Text] [Related]
5. Urea for management of the syndrome of inappropriate secretion of ADH: A systematic review.
de Solà-Morales O; Riera M
Endocrinol Nutr; 2014 Nov; 61(9):486-92. PubMed ID: 24954885
[TBL] [Abstract][Full Text] [Related]
6. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.
Decaux G; Unger J; Brimioulle S; Mockel J
JAMA; 1982 Jan 22-29; 247(4):471-4. PubMed ID: 7054549
[TBL] [Abstract][Full Text] [Related]
7. Hyponatremia in the postoperative craniofacial pediatric patient population: a connection to cerebral salt wasting syndrome and management of the disorder.
Levine JP; Stelnicki E; Weiner HL; Bradley JP; McCarthy JG
Plast Reconstr Surg; 2001 Nov; 108(6):1501-8. PubMed ID: 11711918
[TBL] [Abstract][Full Text] [Related]
8. Syndrome of inappropriate secretion of anti-diuretic hormone due to hypothalamic hamartoma: use of tolvaptan.
Moon RJ; Soliman M; Hoogenboom L; Gilbert RD; Bird-Lieberman G; Singh J; Bockenhauer D; Kumaran A
J Pediatr Endocrinol Metab; 2023 Sep; 36(9):895-899. PubMed ID: 37327191
[TBL] [Abstract][Full Text] [Related]
9. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
10. [Approach to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)].
Martin J; Burnier M; Lu H
Rev Med Suisse; 2018 Nov; 14(628):2116-2120. PubMed ID: 30462399
[TBL] [Abstract][Full Text] [Related]
11. Relapsing Syndrome of Inappropriate Antidiuretic Hormone Production Responding to Tolvaptan Treatment in a Patient With a Micronodular Formation of the Posterior Pituitary Gland.
Reinke LM; Seoudy AK; Gärtner F; Rohmann N; Schulte DM; Schreiber S; Jansen O; Laudes M
Exp Clin Endocrinol Diabetes; 2023 Sep; 131(9):472-475. PubMed ID: 37364592
[TBL] [Abstract][Full Text] [Related]
12. Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
Arima H; Goto K; Motozawa T; Mouri M; Watanabe R; Hirano T; Ishikawa SE
Endocr J; 2021 Jan; 68(1):17-29. PubMed ID: 32863282
[TBL] [Abstract][Full Text] [Related]
13. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
14. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone.
Decaux G; Musch W
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1175-84. PubMed ID: 18434618
[TBL] [Abstract][Full Text] [Related]
15. [Hyponatraemia associated with the syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH) - options for treatment].
Rudnay M; Hrabčáková P; Lazúrová I
Vnitr Lek; 2012 Jan; 58(1):52-5. PubMed ID: 22448701
[TBL] [Abstract][Full Text] [Related]
16. Management of the syndrome of inappropriate secretion of antidiuretic hormone.
Kinzie BJ
Clin Pharm; 1987 Aug; 6(8):625-33. PubMed ID: 3121240
[TBL] [Abstract][Full Text] [Related]
17. Etiology of postoperative hyponatremia following pediatric intracranial tumor surgery.
Williams CN; Riva-Cambrin J; Bratton SL
J Neurosurg Pediatr; 2016 Mar; 17(3):303-9. PubMed ID: 26613271
[TBL] [Abstract][Full Text] [Related]
18. Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.
Potts MB; DeGiacomo AF; Deragopian L; Blevins LS
Neurosurgery; 2011 Aug; 69(2):268-73. PubMed ID: 21792136
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.
Olchovsky D; Ezra D; Vered I; Hadani M; Shimon I
J Endocrinol Invest; 2005 Feb; 28(2):151-6. PubMed ID: 15887861
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.
Soupart A; Coffernils M; Couturier B; Gankam-Kengne F; Decaux G
Clin J Am Soc Nephrol; 2012 May; 7(5):742-7. PubMed ID: 22403276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
